Related Experiment Video
Updated: Jul 13, 2026
12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Prospect of manufacturing and design based on physiological polymorphism
Masashi Nakamura1, Teruhiko Fuwa, Kaoru Inoue
1Division of Forest and Biomaterials Science, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606- 8502, Japan. nakamasa@kais.kyoto-u.ac.jp
Journal of Physiological Anthropology
|August 21, 2007
Summary
Manufacturing and design must consider human physiological polymorphism for user satisfaction. This approach moves beyond average data to embrace individual variations for better product development.
Area of Science:
- Human-centered design
- Physiological anthropology
- Manufacturing innovation
Background:
- Modern manufacturing demands user satisfaction alongside cost-effectiveness.
- Rapid technological shifts necessitate adaptive design strategies.
- Current reliance on average physiological data limits product personalization.
Purpose of the Study:
- To introduce the concept of manufacturing and design based on physiological polymorphism.
- To explore applications of this concept across diverse fields.
- To propose a procedure for implementing polymorphic design.
Main Methods:
- Reviewing the limitations of average-value interpretation in physiological data.
- Applying principles of physiological anthropology to design.
- Discussing methodologies across seven application areas.
Main Results:
- Concept of manufacturing and design based on physiological polymorphism is established.
- Identified seven key fields for application: welfare equipment, clothing, artificial tissue, sporting gear, furniture, building materials, and human interface.
- Developed a procedural framework for polymorphic design.
Conclusions:
- Physiological polymorphism is crucial for creating user-satisfying products.
- A shift from average-based design to polymorphic design is essential for future manufacturing.
- The proposed framework enables tailored product development considering human variability.
Related Concept Videos
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:15Model Approaches for Pharmacokinetic Data: Physiological Models
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...